Beremagene geperpavec (English Wikipedia)
Analysis of information sources in references of the Wikipedia article "Beremagene geperpavec" in English language version.
refsWebsite
Global rank
English rank
1st place
1st place
234th place
397th place
11th place
8th place
doi.org
- "First herpesvirus gene therapy". Nature Biotechnology. 41 (6): 739. June 2023. doi:10.1038/s41587-023-01835-3. PMID 37316736. S2CID 259157518. Archived from the original on 20 June 2023. Retrieved 19 June 2023.
europa.eu
ema.europa.eu
- "Vyjuvek EPAR". European Medicines Agency (EMA). 27 February 2025. Retrieved 4 March 2025. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
ec.europa.eu
- "Vyjuvek PI". Union Register of medicinal products. 24 April 2025. Retrieved 3 May 2025.
fda.gov
- "FDA Approves First Topical Gene Therapy for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa". U.S. Food and Drug Administration (FDA) (Press release). 19 May 2023. Archived from the original on 27 May 2023. Retrieved 28 May 2023.
This article incorporates text from this source, which is in the public domain. - "Vyjuvek". U.S. Food and Drug Administration (FDA). 19 May 2023. 125774. Archived from the original on 24 May 2023. Retrieved 30 May 2023. This article incorporates text from this source, which is in the public domain.
nature.com
- "First herpesvirus gene therapy". Nature Biotechnology. 41 (6): 739. June 2023. doi:10.1038/s41587-023-01835-3. PMID 37316736. S2CID 259157518. Archived from the original on 20 June 2023. Retrieved 19 June 2023.
nih.gov
dailymed.nlm.nih.gov
- "Vyjuvek kit". DailyMed. 19 May 2023. Archived from the original on 21 June 2023. Retrieved 20 June 2023.
pubmed.ncbi.nlm.nih.gov
- "First herpesvirus gene therapy". Nature Biotechnology. 41 (6): 739. June 2023. doi:10.1038/s41587-023-01835-3. PMID 37316736. S2CID 259157518. Archived from the original on 20 June 2023. Retrieved 19 June 2023.
semanticscholar.org
api.semanticscholar.org
- "First herpesvirus gene therapy". Nature Biotechnology. 41 (6): 739. June 2023. doi:10.1038/s41587-023-01835-3. PMID 37316736. S2CID 259157518. Archived from the original on 20 June 2023. Retrieved 19 June 2023.
web.archive.org
- "Vyjuvek kit". DailyMed. 19 May 2023. Archived from the original on 21 June 2023. Retrieved 20 June 2023.
- "FDA Approves First Topical Gene Therapy for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa". U.S. Food and Drug Administration (FDA) (Press release). 19 May 2023. Archived from the original on 27 May 2023. Retrieved 28 May 2023. This article incorporates text from this source, which is in the public domain.
- "First herpesvirus gene therapy". Nature Biotechnology. 41 (6): 739. June 2023. doi:10.1038/s41587-023-01835-3. PMID 37316736. S2CID 259157518. Archived from the original on 20 June 2023. Retrieved 19 June 2023.
- "Vyjuvek". U.S. Food and Drug Administration (FDA). 19 May 2023. 125774. Archived from the original on 24 May 2023. Retrieved 30 May 2023. This article incorporates text from this source, which is in the public domain.